EKO International Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EKNL research report →
Companywww.ekointl.com
EKO International Corp. , through its joint venture interest in NeuroVasc Clinical Inc. , promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada.
- CEO
- Rocky DiBenedetto
- IPO
- 1997
- Employees
- 8
- HQ
- Burlington, ON, CA
Price Chart
Valuation
- Market Cap
- $3.17K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 386.14%
- ROIC
- 34.17%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-801,504 · 0.00%
- EPS
- $0.00 · 0.00%
- Op Income
- $-725,284
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 7.96
- Avg Volume
- 491
Get TickerSpark's AI analysis on EKNL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EKNL Coverage
We haven't published any research on EKNL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EKNL Report →